T-Lymphocyte Phenotypic and Mitochondrial Parameters as Markers of Incomplete Immune Restoration in People Living with HIV+ on Long-Term cART.

: Restored CD4 absolute counts (CD4AC) and CD4/CD8 ratio in the setting of continuous antiretroviral treatment (ART) do not exclude a low-level immune activation associated with HIV reservoirs, microbial translocation, or the side effects of ART itself, which accelerates the aging of people living with HIV (PLHIV). To delineate biomarkers of incomplete immune restoration in PLHIV on successful ART, we evaluated T-lymphocyte mitochondrial parameters in relation to phenotypic markers of immune exhaustion and senescence. : PLHIV with sustained viral suppression, CD4AC > 500 and CD4/CD8 ratio >0.9 on ART ( = 39) were compared to age-matched ART-naïve donors ( = 27) and HIV(-) healthy controls (HC, = 35). CD4 and CD8 differentiation and effector subsets (CCR7/CD45RA and CD27/CD28), activation, exhaustion, and senescence markers (CD38, CD39 Treg, CD57, TIGIT, and PD-1) were determined by flow cytometry. Mitochondrial mass (MM) and membrane potential (MMP) of CD8 and CD4 T cells were evaluated with MitoTracker Green and Red flow cytometry dyes. : ART+PLHIV differed from HC by increased CD4 TEMRA (5.3 (2.1-8.8) vs. 3.2 (1.6-4.4), < 0.05), persistent TIGIT+CD57-CD27+CD28- CD8+ subset (53.9 (45.5-68.9) vs. 40.1 (26.7-58.5), < 0.05), and expanding preapoptotic TIGIT-CD57+CD8+ effectors (9.2 (4.3-21.8) vs. 3.0 (1.5-7.3), < 0.01) in correlation with increased CD8+ MMP (2527 (1675-4080) vs.1477 (1280-1691), < 0.01). These aberrations were independent of age, time to ART, or ART duration, and were combined with increasing CD4 T cell MMP and MM. : In spite of recovered CD4AC and CD4/CD8 ratio, the increased CD8+ MMP, combined with elevated markers of exhaustion and senescence in ART+PLHIV, signals a malfunction of the CD8 effector pool that may compromise viral reservoir latency.